Identification of Amino Acid Residues Important for Heparan Sulfate Proteoglycan Interaction within Variable Region 3 of the Feline Immunodeficiency Virus Surface Glycoprotein

Journal of Virology

Volumn 85, Issue 14, 2011, Pages 7108-7117

  Hu, Qiong Ying ^a   Fink, Elizabeth ^a   Happer, Meaghan ^a   Elder, John H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CHEMOKINE RECEPTOR CXCR4; GLUTAMIC ACID; GLYCOPROTEIN GP 95; LYSINE; PEPTIDE DERIVATIVE; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG; V3 PEPTIDE; VIRUS GLYCOPROTEIN;

AMINO ACID ANALYSIS; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROTEIN TARGETING; RECEPTOR BINDING; RESIDUE ANALYSIS; SITE DIRECTED MUTAGENESIS; VIRUS ENVELOPE; VIRUS STRAIN;

AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; BASE SEQUENCE; CATS; CELL LINE; DNA PRIMERS; FLOW CYTOMETRY; GLYCOPROTEINS; HEPARAN SULFATE PROTEOGLYCANS; IMMUNODEFICIENCY VIRUS, FELINE; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; POLYMERASE CHAIN REACTION; PROTEIN BINDING; RECEPTORS, CXCR4; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL ENVELOPE PROTEINS;

FELINE IMMUNODEFICIENCY VIRUS;

EID: 79960429239     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00573-11     Document Type: Article

References (63)

1. Akhtar, J., and D. Shukla. 2009. Viral entry mechanisms, cellular and viral mediators of herpes simplex virus entry. FEBS J., 276, 7228-7236.
2. Andrianov, A. M., and V. G. Veresov. 2007. Structural analysis of the HIV-1 gp120 V3 loop, application to the HIV-Haiti isolates. J. Biomol. Struct. Dyn., 24, 597-608.
3. Bobardt, M. D., et al. 2003. Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity, 18, 27-39.
4. Cardin, A. D., and H. J. Weintraub. 1989. Molecular modeling of proteinglycosaminoglycan interactions. Arteriosclerosis, 9, 21-32.
5. de Parseval, A., et al. 2005. A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs. J. Biol. Chem., 280, 39493-39504.
6. de Parseval, A., U. Chatterji, P. Sun, and J. H. Elder. 2004. Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc. Natl. Acad. Sci. U. S. A.,, 101, 13044-13049.
7. de Parseval, A., and J. H. Elder. 2001. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells, role of CXCR4, cellsurface heparans, and an unidentified non-CXCR4 receptor. J. Virol., 75, 4528-4539.
8. de Parseval, A., D. L. Lerner, P. Borrow, B. J. Willett, and J. H. Elder. 1997. Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding. J. Virol., 71, 5742-5749.
9. de Parseval, A., S. Ngo, P. Sun, and J. H. Elder. 2004. Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication. J. Virol., 78, 9132-9143.
10. de Parseval, A., S. V. Su, J. H. Elder, and B. Lee. 2004. Specific interaction of feline immunodeficiency virus surface glycoprotein with human DCSIGN. J. Virol., 78, 2597-2600.
11. Elder, J. H., et al. 2008. Molecular mechanisms of FIV infection. Vet. Immunol. Immunopathol., 123, 3-13.
12. Esko, J. D., and S. B. Selleck. 2002. Order out of chaos, assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem., 71, 435-471.
13. Esko, J. D., T. E. Stewart, and W. H. Taylor. 1985. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. U. S. A.,, 82, 3197-3201.
14. Fouchier, R. A., et al. 1992. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol., 66, 3183-3187.
15. Gallay, P. 2004. Syndecans and HIV-1 pathogenesis. Microbes Infect., 6, 617-622.
16. Geijtenbeek, T. B., A. Engering, and Y. Van Kooyk. 2002. DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology. J. Leukoc. Biol., 71, 921-931.
17. Gout, E., G. Schoehn, D. Fenel, H. Lortat-Jacob, and P. Fender. 2010. The adenovirus type 3 dodecahedron's RGD loop comprises an HSPG binding site that influences integrin binding. J. Biomed. Biotechnol., 2010, 541939.
18. Hamon, M., et al. 2004. A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1). Glycobiology, 14, 311-323.
19. Hilgard, P., and R. Stockert. 2000. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology, 32, 1069-1077.
20. Hu, Q. Y., et al. 2010. Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein. PLoS One 5, e10689.
21. Johnson, G., C. Swart, and S. W. Moore. 2008. Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain. Biochem. J., 411, 507-514.
22. Johnston, J. C., et al. 1999. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol., 73, 4991-5000.
23. Jones, K. S., C. Petrow-Sadowski, D. C. Bertolette, Y. Huang, and F. W. Ruscetti. 2005. Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. J. Virol., 79, 12692-12702.
24. Kang, B. S., et al. 2003. PDZ tandem of human syntenin, crystal structure and functional properties. Structure, 11, 459-468.
25. Kuschert, G. S., et al. 1998. Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry (Mosc.), 37, 11193-11201.
26. Lerner, D. L., and J. H. Elder. 2000. Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells. J. Virol., 74, 1854-1863.
27. Lerner, D. L., C. K. Grant, A. de Parseval, and J. H. Elder. 1998. FIV infection of IL-2-dependent and -independent feline lymphocyte lines, host cells range distinctions and specific cytokine upregulation. Vet. Immunol. Immunopathol., 65, 277-297.
28. Levy, P., et al. 1990. Altered expression of proteoglycans in E1A-immortalized rat fetal intestinal epithelial cells in culture. Cancer Res., 50, 6716-6722.
29. Liu, J., and S. C. Thorp. 2002. Cell surface heparan sulfate and its roles in assisting viral infections. Med. Res. Rev., 22, 1-25.
30. Lortat-Jacob, H., A. Grosdidier, and A. Imberty. 2002. Structural diversity of heparan sulfate binding domains in chemokines. Proc. Natl. Acad. Sci. U. S. A., 99, 1229-1234.
31. Lyon, M., and J. T. Gallagher. 1998. Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion. Matrix Biol., 17, 485-493.
32. Moulard, M., et al. 2000. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J. Virol., 74, 1948-1960.
33. Mulloy, B., and R. J. Linhardt. 2001. Order out of complexity-protein structures that interact with heparin. Curr. Opin. Struct. Biol., 11, 623-628.
34. Oh, E. S., J. R. Couchman, and A. Woods. 1997. Serine phosphorylation of syndecan-2 proteoglycan cytoplasmic domain. Arch. Biochem. Biophys., 344, 67-74.
35. Olmsted, R. A., V. M. Hirsch, R. H. Purcell, and P. R. Johnson. 1989. Nucleotide sequence analysis of feline immunodeficiency virus, genome organization and relationship to other lentiviruses. Proc. Natl. Acad. Sci. U. S. A., 86, 8088-8092.
36. Patel, M., et al. 1993. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res. Hum. Retroviruses, 9, 167-174.
37. Pedersen, N. C., E. W. Ho, M. L. Brown, and J. K. Yamamoto. 1987. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science, 235, 790-793.
38. Perrimon, N., and M. Bernfield. 2000. Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404, 725-728.
39. Phillips, T. R., et al. 1990. Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol., 64, 4605-4613.
40. Podell, M., W. R. Buck, K. A. Hayes, M. A. Gavrilin, and L. E. Mathes. 2002. Animal models of retroviral encephalopathies, feline model. Curr. Protoc. Neurosci., 9, 9.9.1-9.9.30.
41. Richardson, J., et al. 1999. Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. J. Virol., 73, 3661-3671.
42. Roderiquez, G., et al. 1995. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J. Virol., 69, 2233-2239.
43. Saphire, A. C., M. D. Bobardt, Z. Zhang, G. David, and P. A. Gallay. 2001. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol., 75, 9187-9200.
44. Sasisekharan, R., Z. Shriver, G. Venkataraman, and U. Narayanasami. 2002. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer., 2, 521-528.
45. Shafti-Keramat, S., et al. 2003. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J. Virol., 77, 13125-13135.
46. Shepherd, T. R., et al. 2010. The Tiam1 PDZ domain couples to Syndecan1 and promotes cell-matrix adhesion. J. Mol. Biol., 398, 730-746.
47. Shih, P. C., et al. 2009. A turn-like structure "KKPE" segment mediates the specific binding of viral protein A27 to heparin and heparan sulfate on cell surfaces. J. Biol. Chem., 284, 36535-36546.
48. Shimojima, M., et al. 2004. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science, 303, 1192-1195.
49. Siebelink, K. H., J. A. Karlas, G. F. Rimmelzwaan, A. D. Osterhaus, and M. L. Bosch. 1995. A determinant of feline immunodeficiency virus involved in Crandell feline kidney cell tropism. Vet. Immunol. Immunopathol., 46, 61-69.
50. Spillmann, D. 2001. Heparan sulfate, anchor for viral intruders? Biochimie, 83, 811-817.
51. Stringer, S. E., et al. 2002. Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha. Blood, 100, 1543-1550.
52. Sundstrom, M., et al. 2008. Mapping of the CXCR4 binding site withinvariable region 3 of the feline immunodeficiency virus surface glycoprotein. J. Virol., 82, 9134-9142.
53. Talbott, R. L., et al. 1989. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A., 86, 5743-5747.
54. Tuve, S., et al. 2008. Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. PLoS Pathog., 4, e1000189.
55. Ugolini, S., I. Mondor, and Q. J. Sattentau. 1999. HIV-1 attachment, another look. Trends Microbiol., 7, 144-149.
56. Uhl, E. W., M. Martin, J. K. Coleman, and J. K. Yamamoto. 2008. Advances in FIV vaccine technology. Vet. Immunol. Immunopathol., 123, 65-80.
57. Verschoor, E. J., et al. 1995. A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells. J. Virol., 69, 4752-4757.
58. Vives, R. R., et al. 2004. A novel strategy for defining critical amino acid residues involved in protein/glycosaminoglycan interactions. J. Biol. Chem., 279, 54327-54333.
59. Willett, B. J., et al. 1998. The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus. J. Virol., 72, 6475-6481.
60. Willett, B. J., and M. J. Hosie. 2008. Chemokine receptors and costimulatory molecules, unravelling feline immunodeficiency virus infection. Vet. Immunol. Immunopathol., 123, 56-64.
61. Willett, B. J., et al. 1997. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol., 71, 6407-6415.
62. Yamashita, H., K. Beck, and Y. Kitagawa. 2004. Heparin binds to the laminin alpha4 chain LG4 domain at a site different from that found for other laminins. J. Mol. Biol., 335, 1145-1149.
63. Yu, W., and J. S. Hill. 2006. Mapping the heparin-binding domain of human hepatic lipase. Biochem. Biophys. Res. Commun., 343, 659-665.